ArticleCancers2022
Two Decades of Brain Tumour Imaging with O-(2-[
Open access · goldAbstract read
In one paragraph
Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 21 citations in OpenAlex.
- Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.Neuro-oncology · 2025Review
- An effective MRI perfusion threshold based workflow to triage additionalScientific reports · 2025Article
- PET imaging of gliomas: Status quo and quo vadis?Neuro-oncology · 2024Review
- Article
- The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.European journal of nuclear medicine and molecular imaging · 2024Article
- Assessment of Brain Tumour Perfusion Using Early-PhaseMolecular imaging and biology · 2024Article
- Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06.European journal of nuclear medicine and molecular imaging · 2023Article
- Boosting the acceptance ofEuropean journal of nuclear medicine and molecular imaging · 2023Article
- Review
- HybridJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023Article
- Radiosynthesis and Analysis of (S)-4-(3-[Molecular imaging and biology · 2023Article
- Multi-threshold volumetricNeuro-oncology advancesArticle
- Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors at 8 institutions in 2 countries.
Alexander HeinzelDepartment of Nuclear Medicine, RWTH University Hospital, D-52074 Aachen, Germany.
Daniela DedicDepartment of Nuclear Medicine, RWTH University Hospital, D-52074 Aachen, Germany.
Norbert GalldiksInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.
Philipp LohmannInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0002-5360-046X
Gabriele StoffelsInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.
Christian P FilssDepartment of Nuclear Medicine, RWTH University Hospital, D-52074 Aachen, Germany.
Martin KocherInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.
Filippo MiglioriniDepartment of Orthopedics, Trauma, and Reconstructive Surgery, RWTH University Hospital, D-52074 Aachen, Germany.ORCID 0000-0001-7220-1221
Kim N H DillenDepartment of Palliative Medicine, University Hospital Cologne, D-50937 Cologne, Germany.
Stefanie GeislerInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0001-8894-3369
Carina StegmayrInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.
Antje WilluweitInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0002-6725-0755
Michael SabelCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Marion RappCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Michael J EbleCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Marc PirothDepartment of Radiation Oncology, Helios University Hospital Wuppertal, Witten/Herdecke University, D-42283 Wuppertal, Germany.
Hans ClusmannCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Daniel DelevCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Elena K BauerCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Garry CecconCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Veronika DunklCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Jurij RosenCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Caroline TscherpelCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Jan-Michael WernerCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.ORCID 0000-0001-7147-4594
Maximilian I RugeCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Roland GoldbrunnerCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Jürgen HamplCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Carolin Weiss LucasCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Ulrich HerrlingerCenter of Integrated Oncology (CIO), University of Aachen, D-52074 Aachen, D-53127 Bonn, D-50937 Cologne, D-40225 Düsseldorf, Germany.
Gabriele D MaurerDr. Senckenberg Institute of Neurooncology, University Cancer Center Frankfurt (UCT), Goethe University Hospital, D-60528 Frankfurt am Main, Germany.
Joachim P SteinbachDr. Senckenberg Institute of Neurooncology, University Cancer Center Frankfurt (UCT), Goethe University Hospital, D-60528 Frankfurt am Main, Germany.
Jörg MaulerInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0003-4937-0355
Wieland A WorthoffInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0001-9121-8790
Bernd N NeumaierInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0001-5425-3116
Christoph LercheInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0003-2749-2108
Gereon R FinkInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0002-8230-1856
Nadim Jon ShahInstitute of Neuroscience and Medicine (INM-3, INM-4, INM-5, INM-11), Forschungszentrum Jülich, D-52425 Jülich, Germany.ORCID 0000-0002-8151-6169
Felix M MottaghyDepartment of Nuclear Medicine, RWTH University Hospital, D-52074 Aachen, Germany.ORCID 0000-0002-7212-6521
Karl-Josef LangenDepartment of Nuclear Medicine, RWTH University Hospital, D-52074 Aachen, Germany.ORCID 0000-0003-1101-5075
Forschungszentrum Jülich · DEUniversity Hospital Cologne · DERWTH Aachen University · DEDüsseldorf University Hospital · DEGoethe University Frankfurt · DEMaastricht University · NLUniversity of Bonn · DEWitten/Herdecke University · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
O-(2-[
Indexed as
amino acid PETbrain metastasisbrain tumour diagnosisgliomaO-(2-[18F]fluoroethyl)-L-tyrosine (FET)positron emission tomography
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.